Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Chimerix (CMRX) has a market cap of $0.80 billion USD. According to our data, Chimerix is ranked No.5345 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.80 B |
156.15%
|
| Dec 31, 2024 | $0.31 B |
262.50%
|
| Dec 29, 2023 | $86.37 M |
-48.39%
|
| Dec 30, 2022 | $0.17 B |
-71.07%
|
| Dec 31, 2021 | $0.58 B |
33.13%
|
| Dec 31, 2020 | $0.43 B |
137.93%
|
| Dec 31, 2019 | $0.18 B |
-21.01%
|
| Dec 31, 2018 | $0.23 B |
-44.49%
|
| Dec 29, 2017 | $0.42 B |
0.65%
|
| Dec 30, 2016 | $0.41 B |
-48.60%
|
| Dec 31, 2015 | $0.81 B |
-77.77%
|
| Dec 31, 2014 | $3.62 B |
166.45%
|
| Dec 31, 2013 | $1.36 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
| Market Cap | = | CMRX Stock Price | * | CMRX Shares Outstanding |
| = | $8.55 | * | 93.80 M | |
| = | $0.80 B |